
The Ministry of Health announced financing of HPV vaccinations for people aged 18-26 in a three-dose schedule, valid from today until May 31, 2027, extending the previous program for children 9-14 years old, effective from September 1, 2024.
AI-generated summary
HPV is the virus responsible for cervical cancer and other cancers. From September 1, 2024, vaccinations are available for children aged 9–14 as part of a universal program.
HPV vaccination. The Ministry of Health is introducing an important change
HPV (Human Papilloma Virus) is the name of the human papillomavirus; it is responsible for the incidence of cervical cancer and other cancers.
The announcement of the Ministry of Health of September 30 provides for financing of HPV vaccination for people over 18 years of age until they turn 26 years of age, in a three-dose schedule. According to the document, financing starts today and will last until May 31, 2027.
From September 1, 2024, vaccinations under the universal HPV vaccination program are available to people from 9 years of age to 14 years of age.
What does the new announcement assume?

The Bielsko Sanepid issued a ban on drinking water in Bystra and selected streets of Bielsko-Biała due to the detection of the Clostridium perfringens bacteria. Water may only be used to flush toilets.

Prof. Mariusz Kuśmierczyk explains in the Radio RMF24 podcast the importance of the great saphenous vein in cardiac surgery, the evolutionary remains of the human body, the extraordinary regenerative abilities of the liver and organ transplant procedures.

The right to NFZ benefits is available to students registered for insurance by their parents, university or employer. A parent's change of job, turning 26 or summer employment may require re-notification.

At the Multi-Specialty Hospital in Nowa Sól, irregularities were detected in medical records - patients were diagnosed with an acute heart attack without any basis for such a diagnosis, which prevented access to some medications. The National Health Fund's inspection is intended to explain why as many as three quarters of cardiac procedures in the hospital concerned the treatment of acute coronary syndrome, while in other facilities the proportions are opposite. The hospital authorities explain this by specializing in serious cases and accepting patients from the entire Lubuskie Voivodeship.

Retatrutide, a new drug for obesity and type 2 diabetes, shows spectacular results in clinical trials, allowing patients to lose up to 18.8% on average. body weight and improving glycemic control.

Prof. Maciej Wybraniec from the Upper Silesian Medical Center discusses the prevention of heart diseases, the importance of diet, physical activity and modern methods of treating heart attacks in Poland, emphasizing the importance of regular check-ups after the age of 40.